Literature DB >> 12657884

Annexin II/p11 is up-regulated in Purkinje cells in EAE and MS.

Matthew J Craner1, Albert C Lo, Joel A Black, David Baker, Jia Newcombe, M Louise Cuzner, Stephen G Waxman.   

Abstract

The sensory neuron specific sodium channel Na(v)1.8 is normally detectable at only very low levels within cerebellar Purkinje cells. Annexin II light chain (p11) binds to the amino terminus of Na(v)1.8 and facilitates its functional expression within the cell membrane. We previously demonstrated that expression of Na(v)1.8 is up-regulated in cerebellar Purkinje cells in experimental allergic encephalomyelitis (EAE) and multiple sclerosis (MS). In this study we demonstrate that expression of p11 is significantly up-regulated in Purkinje cells in EAE (71 +/- 9.0% vs 21.3 +/- 4.9% in controls) and in MS(65.5 +/- 1.6% vs 21.8 +/- 6.2% in controls). We also demonstrate a high degree of co-expression of p11 and Na(v)1.8 (84.8 +/- 8.9%). Together with earlier results which show that experimental expression of Na(v)1.8 within Purkinje cells perturbs the temporal pattern of impulse generation in these cells, our results extend the evidence for an acquired channelopathy which interferes with cerebellar function in MS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657884     DOI: 10.1097/00001756-200303240-00005

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  12 in total

1.  Abnormal Purkinje cell activity in vivo in experimental allergic encephalomyelitis.

Authors:  Carl Y Saab; Matthew J Craner; Yuko Kataoka; Stephen G Waxman
Journal:  Exp Brain Res       Date:  2004-04-29       Impact factor: 1.972

2.  Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord.

Authors:  Tong Liu; K Christian Donahue; Jun Hu; Michael P Kurnellas; Jennifer E Grant; Hong Li; Stella Elkabes
Journal:  J Proteome Res       Date:  2007-06-16       Impact factor: 4.466

3.  Animal models of human cerebellar ataxias: a cornerstone for the therapies of the twenty-first century.

Authors:  Mario Manto; Daniele Marmolino
Journal:  Cerebellum       Date:  2009-09       Impact factor: 3.847

4.  Insertion of the beta Geo promoter trap into the Fem1c gene of ROSA3 mice.

Authors:  Cassandra L Schlamp; Andrew T Thliveris; Yan Li; Louis P Kohl; Claudia Knop; Joel A Dietz; Inna V Larsen; Pascal Imesch; Lawrence H Pinto; Robert W Nickells
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

5.  Proteomic strategies in multiple sclerosis and its animal models.

Authors:  Stella Elkabes; Hong Li
Journal:  Proteomics Clin Appl       Date:  2007-10-16       Impact factor: 3.494

6.  Cuprizone treatment induces distinct demyelination, astrocytosis, and microglia cell invasion or proliferation in the mouse cerebellum.

Authors:  Angela Groebe; Tim Clarner; Werner Baumgartner; Jon Dang; Cordian Beyer; Markus Kipp
Journal:  Cerebellum       Date:  2009-03-04       Impact factor: 3.847

7.  Cerebrospinal fluid and blood biomarkers of neuroaxonal damage in multiple sclerosis.

Authors:  Irena Dujmovic
Journal:  Mult Scler Int       Date:  2011-05-02

8.  Purkinje Cell Pathology and Loss in Multiple Sclerosis Cerebellum.

Authors:  Juliana Redondo; Kevin Kemp; Kelly Hares; Claire Rice; Neil Scolding; Alastair Wilkins
Journal:  Brain Pathol       Date:  2014-12-31       Impact factor: 6.508

Review 9.  Cerebellar Dysfunction in Multiple Sclerosis.

Authors:  Alastair Wilkins
Journal:  Front Neurol       Date:  2017-06-28       Impact factor: 4.003

Review 10.  Sodium channels and multiple sclerosis: roles in symptom production, damage and therapy.

Authors:  Kenneth J Smith
Journal:  Brain Pathol       Date:  2007-04       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.